Further genetic and clinical insights of posterior polymorphous corneal dystrophy 3

JAMA Ophthalmology

Volumn 131, Issue 10, 2013, Pages 1296-1303

  Liskova, Petra ^a,b   Palos, Michalis ^b   Hardcastle, Alison J ^c   Vincent, Andrea L ^d,e  

^a Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR ZEB1;

ADULT; ARTICLE; ASTIGMATISM; BODY MASS; CAPSULE OPACIFICATION; CASE REPORT; CONTROLLED STUDY; CONVERGENT STRABISMUS; CORNEA DYSTROPHY; CORNEA EDEMA; CORNEA THICKNESS; CORNEAL PACHYMETRY; DENSITY; ENDOTHELIUM CELL; EXON; FEMALE; FOLLOW UP; FRAMESHIFT MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HYDROCELE; INGUINAL HERNIA; KERATOCONUS; KERATOMETRY; MALE; PHENOTYPE; POSTERIOR POLYMORPHOUS CORNEAL DYSTROPHY; PRIORITY JOURNAL; RARE DISEASE; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SPECULAR MICROSCOPY; VISUAL ACUITY;

CELL COUNT; CORNEAL DYSTROPHIES, HEREDITARY; CORNEAL ENDOTHELIAL CELL LOSS; CORNEAL PACHYMETRY; CORNEAL TOPOGRAPHY; ENDOTHELIUM, CORNEAL; EXONS; FEMALE; FRAMESHIFT MUTATION; HOMEODOMAIN PROTEINS; HUMANS; INTRAOCULAR PRESSURE; MALE; MOLECULAR BIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; VISUAL ACUITY; YOUNG ADULT;

EID: 84885932365     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.405     Document Type: Article

References (42)

1. Liskova P, Gwilliam R, Filipec M, et al. High prevalence of posterior polymorphous corneal dystrophy in the Czech Republic; linkage disequilibrium mapping and dating an ancestral mutation. PLoS One. 2012;7(9):e45495. doi:10.1371/journal.pone.0045495.
2. Rodrigues MM, Waring GO, Laibson PR, Weinreb S. Endothelial alterations in congenital corneal dystrophies. Am J Ophthalmol. 1975;80(4): 678-689.
3. Krachmer JH. Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis. Trans Am Ophthalmol Soc. 1985;83:413-475. (Pubitemid 17210928)
4. Threlkeld AB, Green WR, Quigley HA, de la Cruz Z, Stark WJ. A clinicopathologic study of posterior polymorphous dystrophy: implications for pathogenetic mechanism of the associated glaucoma. Trans Am Ophthalmol Soc. 1994;92:133-165.
5. Jirsova K, Merjava S, Martincova R, et al. Immunohistochemical characterization of cytokeratins in the abnormal corneal endothelium of posterior polymorphous corneal dystrophy patients. Exp Eye Res. 2007;84(4):680-686. (Pubitemid 46400634)
6. Liskova P, Filipec M, Merjava S, Jirsova K, Tuft SJ. Variable ocular phenotypes of posterior polymorphous corneal dystrophy caused by mutations in the ZEB1 gene. Ophthalmic Genet. 2010;31(4):230-234.
7. Merjava S, Liskova P, Sado Y, Davis PF, Greenhill NS, Jirsova K. Changes in the localization of collagens IV and VIII in corneas obtained from patients with posterior polymorphous corneal dystrophy. Exp Eye Res. 2009;88(5):945-952.
8. Héon E, Mathers WD, Alward WL, et al. Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum Mol Genet. 1995;4(3):485-488.
9. Gwilliam R, Liskova P, Filipec M, et al. Posterior polymorphous corneal dystrophy in Czech families maps to chromosome 20 and excludes the VSX1 gene. Invest Ophthalmol Vis Sci. 2005;46(12): 4480-4484. (Pubitemid 44264542)
10. Studeny P, Jirsova K, Kuchynka P, Liskova P. Descemet membrane endothelial keratoplasty with a stromal rim in the treatment of posterior polymorphous corneal dystrophy. Indian J Ophthalmol. 2012;60(1):59-60.
11. DeRespinis PA, Norden RA, Rispoli LC. Posterior polymorphous dystrophy associated with astigmatism and amblyopia in children. J Refract Surg. 1996;12(6):709-714. (Pubitemid 26332972)
12. Raber IM, Fintelmann R, Chhabra S, Ribeiro MP, Eagle RC Jr, Orlin SE. Posterior polymorphous dystrophy associated with nonkeratoconic steep corneal curvatures. Cornea. 2011;30(10):1120-1124.
13. Biswas S, Munier FL, Yardley J, et al. Missense mutations in COL8A2, the gene encoding the α2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 2001;10(21):2415-2423. (Pubitemid 33069547)
14. Heon E, Greenberg A, Kopp KK, et al. VSX1: a gene for posterior polymorphous dystrophy and keratoconus. Hum Mol Genet. 2002;11(9):1029-1036. (Pubitemid 34521084)
15. Krafchak CM, Pawar H, Moroi SE, et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet. 2005;77(5):694-708. (Pubitemid 41513274)
16. Liskova P, Tuft SJ, Gwilliam R, et al. Novel mutations in the ZEB1 gene identified in Czech and British patients with posterior polymorphous corneal dystrophy. Hum Mutat. 2007;28(6):638. doi:10.1002/humu.9495.
17. Aldave AJ, Yellore VS, Yu F, et al. Posterior polymorphous corneal dystrophy is associated with TCF8 gene mutations and abdominal hernia. Am J Med Genet A. 2007;143A(21):2549-2556. (Pubitemid 350058167)
18. Vincent AL, Niederer RL, Richards A, Karolyi B, Patel DV, McGhee CN. Phenotypic characterisation and ZEB1 mutational analysis in posterior polymorphous corneal dystrophy in a New Zealand population. Mol Vis. 2009;15:2544-2553.
19. Liskova P. Molecular genetic study of inherited corneal disorders [doctoral thesis]. London, England: University College London; 2009.
20. Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PE. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat. 2008;29(1):6-13.
21. Galgauskas S, Krasauskaite D, Pajaujis M, Juodkaite G, Asoklis RS. Central corneal thickness and corneal endothelial characteristics in healthy, cataract, and glaucoma patients. Clin Ophthalmol. 2012;6:1195-1199.
22. Rabinowitz YS, Yang H, Brickman Y, et al. Videokeratography database of normal human corneas. Br J Ophthalmol. 1996;80(7):610-616. (Pubitemid 26258144)
23. Ambrósio R Jr. Percentage thickness increase and absolute difference from thinnest to describe thickness profile. J Refract Surg. 2010;26(2):84-87.
24. Ambrósio R Jr, Alonso RS, Luz A, Coca Velarde LG. Corneal-thickness spatial profile and corneal-volume distribution: tomographic indices to detect keratoconus. J Cataract Refract Surg. 2006;32(11):1851-1859. (Pubitemid 44647765)
25. John GR. Videokeratographic abnormalities in a family with posterior polymorphous dystrophy. Cornea. 1998;17(4):380-383. (Pubitemid 28307503)
26. Nguyen DQ, Hosseini M, Billingsley G, Heon E, Churchill AJ. Clinical phenotype of posterior polymorphous corneal dystrophy in a family with a novel ZEB1 mutation. Acta Ophthalmol. 2010;88(6):695-699.
27. Henriquez AS, Kenyon KR, Dohlman CH, et al. Morphologic characteristics of posterior polymorphous dystrophy: a study of nine corneas and review of the literature. Surv Ophthalmol. 1984;29(2):139-147. (Pubitemid 15203568)
28. Primatesta P, Goldacre MJ. Inguinal hernia repair: incidence of elective and emergency surgery, readmission and mortality. Int J Epidemiol. 1996;25(4):835-839. (Pubitemid 26290069)
29. Dong C, Li WD, Geller F, et al. Possible genomic imprinting of three human obesity-related genetic loci. Am J Hum Genet. 2005;76(3):427-437. (Pubitemid 40250523)
30. Hager J, Dina C, Francke S, et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet. 1998;20(3):304-308. (Pubitemid 28507680)
31. Hinney A, Ziegler A, Oeffner F, et al. Independent confirmation of a major locus for obesity on chromosome 10. J Clin Endocrinol Metab. 2000;85(8):2962-2965. (Pubitemid 32269182)
32. Price RA, Li WD, Bernstein A, et al. A locus affecting obesity in human chromosome region 10p12. Diabetologia. 2001;44(3):363-366. (Pubitemid 32234464)
33. Saykally JN, Dogan S, Cleary MP, Sanders MM. The ZEB1 transcription factor is a novel repressor of adiposity in female mice. PLoS One. 2009;4(12):e8460. doi:10.1371/journal.pone.0008460.
34. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet. 2001;109(1):121-124. (Pubitemid 32743202)
35. Khan SG, Oh KS, Emmert S, et al. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms. DNA Repair (Amst). 2009;8(1):114-125.
36. Kets CM, Hoogerbrugge N, van Krieken JH, Goossens M, Brunner HG, Ligtenberg MJ. Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A
37. Wolf A, Caliebe A, Thomas NS, et al. Single base-pair substitutions at the translation initiation sites of human genes as a cause of inherited disease. Hum Mutat. 2011;32(10):1137-1143.
38. Yellore VS, Rayner SA, Nguyen CK, et al. Analysis of the role of ZEB1 in the pathogenesis of posterior polymorphous corneal dystrophy. Invest Ophthalmol Vis Sci. 2012;53(1):273-278.
39. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442-454.
40. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172(7):973-981.
41. Moroi SE, Gokhale PA, Schteingart MT, et al. Clinicopathologic correlation and genetic analysis in a case of posterior polymorphous corneal dystrophy. Am J Ophthalmol. 2003;135(4):461-470. (Pubitemid 36315955)
42. Merjava S, Malinova E, Liskova P, et al. Recurrence of posterior polymorphous corneal dystrophy is caused by the overgrowth of the original diseased host endothelium. Histochem Cell Biol. 2011;136(1):93-101.